Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(2-anilinoethane-1,1-diyl)bis(phosphonic acid)
-
(2E)-2-[(4-nitrophenyl)methylidene]-4,4-diphosphonobutanoic acid
-
2-[2-amino-3-[(2-amino-3-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-3-oxopropyl)disulfanyl]propanamido]-3-(4-hydroxyphenyl)propanoic acid
treating the wild-type Escherichia coli with the inhibitor, at 0.050 mM, results in a metabolic fingerprint that is an almost identicalntical metabolic behavior to the ppk1 knockout mutant
6-(4-aminobenzamido)-5-[(E)-[1-(2-chloro-5-sulfophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-yl]diazenyl]naphthalene-2-sulfonic acid
treating the wild-type Escherichia coli with the inhibitor, at 0.050 mM, results in a metabolic fingerprint that is completely identical to that of ppk1 knockout mutant
Ca2+
-
1 mM, 10% inhibition
Co2+
-
1 mM, 40% inhibition
Cu2+
-
0.1 mM, 92% inhibition, 1 mM, complete inhibition
GMP
-
competitive inhibition of polyphosphate 750 and GDP in guanosine 5'-tetraphosphate synthesis
Guanidine HCl
-
5 mM, 50% inhibition of polyphosphate synthesis
histone
-
reverse reaction, strong, activates forward reaction in the presence of phosphate
Mn2+
-
weak inhibition at 10 mM Mg2+
Polyphosphate
-
65 residues, competitive inhibition of polyphosphate 750 and GDP in guanosine 5'-tetraphosphate synthesis
threonyltyrosyl-N-[(1R)-1-[(3-aminopropyl)amino]-2-(carboxyoxy)-2-oxoethyl]serinamide
poor chemical inhibitor of PPK1, it shows a drop of approximately 20% in the WT biofilm formation ability
Zn2+
-
0.1 mM, 67% inhibition, 1 mM, complete inhibition
[(3-aminoanilino)methylene]bis(phosphonic acid)
-
[(3-carbamimidamidoanilino)methylene]bis(phosphonic acid)
-
[2-(2,3-dichlorophenyl)-1-hydroxyethane-1,1-diyl]bis(phosphonic acid)
-
[2-(3,4-dichlorophenyl)-1-hydroxyethane-1,1-diyl]bis(phosphonic acid)
-
[2-(3-chloroanilino)ethane-1,1-diyl]bis(phosphonic acid)
-
[2-[(1-amino-2-methylbutyl)(hydroxy)phosphoryl]ethyl]phosphonic acid
-
(NH4)2SO4
-
strong inhibition
(NH4)2SO4
-
inhibition at higher concentrations
(NH4)2SO4
-
activation up to 100 mM
ADP
-
ADP
-
0.2 mM, complete inhibition
ADP
-
0.08 mM, complete inhibition
ADP
-
50%, 70% and 93% inhibition at 0.08 mM, 0.15 mM and 0.2 mM ADP, respectively
diphosphate
-
1 mM, complete inhibition
diphosphate
-
weak inhibition
diphosphate
-
10 mM, 66% inhibition of polyphosphate synthesis, 75% inhibition of GTP synthesis
F-
-
5 mM, complete inhibition
F-
-
20 mM, complete inhibition
KCl
-
-
KCl
-
50 mM, 50% inhibition
phosphate
-
above 20 mM
phosphate
-
activates in the presence of histone
additional information
-
not inhibited by 2,4-dinitrophenol or potassium arsenate
-
additional information
-
not inhibited by 3',5'-adenosine monophosphate
-
additional information
-
MIC values of wild-type and mutant strain ExPEC for diverse antibiotics, i.e. beta-lactams cefotaxime, ceftazidime, ampicillin, cefazolin, tazobactam, and ticarcillin, glycopeptide vancomycin, aminoglycosides gentamicin, gentamicin sulfate, amikacin macrolide, erythromycin, quinolones norfloxacin and levofloxacin, sulfonamide trimethoprim, sulfadiazine nitrofurans macrodantin, and lipopeptde polymyxin B, overview. Biofilm-grown DELTAppk and wild-type cells are similarly tolerant and more tolerant than planktonic cells
-
additional information
screening of low-molecular-weight organophosphorus inhibitors against polyphosphate kinases from Cytophaga hutchinsonii and Escherichia coli. For Escherichia coli PPK1, only individual compounds with a distinct scaffold and functional group arrangement show potency
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
metabolism
-
cell growth, hydrogen productivity and cellular metabolism of Enterobacter aerogenes IAM1183 are affected by the external addition of diphosphate and the overexpression of the enzyme at different initial glucose concentrations
drug target
bacterial species, including many pathogens, encode a homolog of a major polyP synthesis enzyme, polyphosphate kinase (PPK) with 2 different genes coding for PPK1 and PPK2. Genetic deletion of the ppk1 gene leads to reduced polyP levels and the consequent loss of virulence and stress adaptation responses. No PPK1 homolog has been identified in higher-order eukaryotes, and, therefore, PPK1 represents a target for chemotherapy
drug target
-
the absence of a polyphosphate kinase orthologue in humans makes it a potential drug target
malfunction
deletion of ppk1 causes loss of virulence for animals
malfunction
-
the isogenic in-frame ppk1 deletion mutant PD44 shows poor survival rates during osmotic shock and acidic challenge and is defective in bacterial adhesion and translocation across the blood-brain-barrier
malfunction
-
planktonic cells of a ppk knockout strain (DELTAppk) are more susceptible to antibiotics than the wild-type strain, while biofilm-grown DELTAppk cells show similar susceptibility compared to the wild-type and are more tolerant than the planktonic cells. Phenotypes, overview
malfunction
a mutant lacking the enzyme (PPK) makes no detectable polyP under any condition
malfunction
gene deletion alters specific metabolic pathways, changing the metabolic fingerprint, and suppressing the ability of Escherichia coli to form a biofilm
malfunction
-
polyphosphate kinase deletion increases sensitivity to H2O2 and reduces polyphosphate accumulation. Polyphosphate kinase deletion upregulates fermentation, aerobic and anaerobic respiration, enhances catalase and Clp protease activity, down-regulates ATP-dependent RNA helicase, DNA polymerase III and pyruvate kinase I
malfunction
-
polyphosphate kinase ppk1 deletion causes poor survival during osmotic shock and acid challenge
physiological function
PPK1 regulates error-prone DNA replication by DNA polymerase IV, leading to adaptive mutation
physiological function
-
polyphosphate kinase 1 is required for the pathogenesis process of meningitic Escherichia coli K1 (RS218) and plays an important role in stress adaption and virulence
physiological function
-
enzyme PPK is important for the antibiotic stress response during the planktonic growth of extraintestinal pathogenic Escherichia coli
physiological function
-
in Escherichia coli polyphosphate levels are controlled via the polyphosphate-synthesizing enzyme polyphosphate kinase (PPK1) and exopolyphosphatases (PPX and GPPA), and are temporarily enhanced by PPK1 overexpression and reduced by PPX overexpression
physiological function
-
the enzyme has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Kornberg, A.; Kornberg, S.R.; Simms, E.S.
metaphosphate synthesis by an enzyme from Escherichia coli
Biochim. Biophys. Acta
20
215-227
1956
Escherichia coli
brenda
Murata, K.; Uchida, T.; Kato, J.; Chibata, I.
Polyphosphate kinase: distribution, some properties and its applicatin as an ATP regeneration system
Agric. Biol. Chem.
52
1471-1477
1988
Achromobacter butyri, Alcaligenes faecalis, Bacillus subtilis, Clavibacter michiganensis subsp. sepedonicus, Corynebacterium ammoniagenes, Escherichia coli, Escherichia coli B / ATCC 11303, Klebsiella aerogenes, Komagataeibacter xylinus, Micrococcus flavus, Micrococcus luteus, Pseudomonas aeruginosa, Sinomonas atrocyanea, [Brevibacterium] flavum
-
brenda
Li, H.C.; Brown, G.G.
Orthophosphate and histone dependent polyphosphate kinase from E. coli
Biochem. Biophys. Res. Commun.
53
875-881
1973
Escherichia coli
brenda
Ahn, K.; Kornberg, A.
Polyphosphate kinase from Escherichia coli. Purification and demonstration of a phosphoenzyme intermediate
J. Biol. Chem.
265
11734-11739
1990
Escherichia coli
brenda
Haeusler, P.A.; Dieter, L.; Rittle, K.J.; Shepler, L.S.; Paszkowski, A.L.; Moe, O.A.
Catalytic properties of Escherichia coli polyphosphate kinase: an enzyme for ATP regeneration
Biotechnol. Appl. Biochem.
15
125-133
1992
Escherichia coli
brenda
Kuroda, A.; Kornberg, A.
Polyphosphate kinase as a nucleoside diphosphate kinase in Escherichia coli and Pseudomonas aeruginosa
Proc. Natl. Acad. Sci. USA
94
439-442
1997
Escherichia coli, Pseudomonas aeruginosa
brenda
Noguchi, T.; Shiba, T.
Use of Escherichia coli polyphosphate kinase for oligosaccharide synthesis
Biosci. Biotechnol. Biochem.
62
1594-1596
1998
Escherichia coli
brenda
Shiba, T.; Tsutsumi, K.; Ishige, K.; Noguchi, T.
Inorganic polyphosphate and polyphosphate kinase: their novel biological functions and applications
Biochemistry
65
315-323
2000
Escherichia coli
brenda
Tzeng, C.M.; Kornberg, A.
The multiple activities of polyphosphate kinase of Escherichia coli and their subunit structure determined by radiation target analysis
J. Biol. Chem.
275
3977-3983
2000
Escherichia coli
brenda
Kameda, A.; Shiba, T.; Kawazoe, Y.; Satoh, Y.; Ihara, Y.; Munekata, M.; Ishige, K.; Noguchi, T.
A novel ATP regeneration system using polyphosphate-AMP phosphotransferase and polyphosphate kinase
J. Biosci. Bioeng.
91
557-563
2001
Escherichia coli
brenda
Zhu, Y.; Lee, S.S.; Xu, W.
Crystallization and characterization of polyphosphate kinase from Escherichia coli
Biochem. Biophys. Res. Commun.
305
997-1001
2003
Escherichia coli
brenda
Zhu, Y.; Huang, W.; Lee, S.S.; Xu, W.
Crystal structure of a polyphosphate kinase and its implications for polyphosphate synthesis
EMBO Rep.
6
681-687
2005
Escherichia coli (P0A7B1), Escherichia coli
brenda
Stumpf, J.D.; Foster, P.L.
Polyphosphate kinase regulates error-prone replication by DNA polymerase IV in Escherichia coli
Mol. Microbiol.
57
751-761
2005
Escherichia coli
brenda
Ezawa, T.; Cavagnaro, T.R.; Smith, S.E.; Smith, F.A.; Ohtomo, R.
Rapid accumulation of polyphosphate in extraradical hyphae of an arbuscular mycorrhizal fungus as revealed by histochemistry and a polyphosphate kinase/luciferase system
New Phytol.
161
387-392
2004
Escherichia coli
brenda
Brown, M.R.; Kornberg, A.
The long and short of it - polyphosphate, PPK and bacterial survival
Trends Biochem. Sci.
33
284-290
2008
Klebsiella aerogenes, Bacillus anthracis, Bacillus cereus, Dictyostelium discoideum, Helicobacter pylori, Myxococcus xanthus, Neisseria meningitidis, Pseudomonas aeruginosa, Escherichia coli (P0A7B1)
brenda
Hooley, P.; Whitehead, M.P.; Brown, M.R.
Eukaryote polyphosphate kinases: is the Kornberg complex ubiquitous?
Trends Biochem. Sci.
33
577-582
2008
Ostreococcus tauri (A0A090M3D0), Methanocorpusculum labreanum (A2SQZ9), Neopyropia yezoensis (A2VBB6), Ostreococcus sp. 'lucimarinus' (A4RQI1), Escherichia coli (P0A7B1), Physcomitrium patens (Q2MEV6), Dictyostelium discoideum (Q54BM7), Dictyostelium discoideum
brenda
Shimane, M.; Sugai, Y.; Kainuma, R.; Natsume, M.; Kawaide, H.
Mevalonate-dependent enzymatic synthesis of amorphadiene driven by an ATP-regeneration system using polyphosphate kinase
Biosci. Biotechnol. Biochem.
76
1558-1560
2012
Escherichia coli
brenda
Lu, Y.; Zhang, C.; Lai, Q.; Zhao, H.; Xing, X.H.
Improved hydrogen production under microaerophilic conditions by overexpression of polyphosphate kinase in Enterobacter aerogenes
Enzyme Microb. Technol.
48
187-192
2011
Escherichia coli
brenda
Peng, L.; Luo, W.Y.; Zhao, T.; Wan, C.S.; Jiang, Y.; Chi, F.; Zhao, W.; Cao, H.; Huang, S.H.
Polyphosphate kinase 1 is required for the pathogenesis process of meningitic Escherichia coli K1 (RS218)
Future Microbiol.
7
411-423
2012
Escherichia coli, Escherichia coli K1 (RS218)
brenda
Lu, Y.; Lai, Q.; Zhang, C.; Zhao, H.; Xing, X.
Alteration of energy metabolism in Enterobacter aerogenes by external addition of pyrophosphates and overexpression of polyphosphate kinase for enhanced hydrogen production
J. Chem. Technol. Biotechnol.
87
996-1003
2012
Escherichia coli
-
brenda
Chen, J.; Su, L.; Wang, X.; Zhang, T.; Liu, F.; Chen, H.; Tan, C.
Polyphosphate kinase mediates antibiotic tolerance in extraintestinal pathogenic Escherichia coli PCN033
Front. Microbiol.
7
724
2016
Escherichia coli, Escherichia coli PCN033
brenda
Liang, M.; Frank, S.; Luensdorf, H.; Warren, M.J.; Prentice, M.B.
Bacterial microcompartment-directed polyphosphate kinase promotes stable polyphosphate accumulation in E. coli
Biotechnol. J.
12
1600415
2017
Escherichia coli
brenda
Burda-Grabowska, M.; Macegoniuk, K.; Flick, R.; Nocek, B.; Joachimiak, A.; Yakunin, A.; Mucha, A.; Berlicki, A.
Bisphosphonic acids and related compounds as inhibitors of nucleotide- and polyphosphate-processing enzymes A PPK1 and PPK2 case study
Chem. Biol. Drug Des.
93
1197-1206
2019
Cytophaga hutchinsonii (A0A6N4SMB5), Escherichia coli (P0A7B1), Cytophaga hutchinsonii DSM 1761 (A0A6N4SMB5)
brenda
Gautam, L.K.; Sharma, P.; Capalash, N.
Bacterial polyphosphate kinases revisited role in pathogenesis and therapeutic potential
Curr. Drug Targets
20
292-301
2019
Bacillus cereus, Porphyromonas gingivalis, Escherichia coli, Francisella tularensis, Helicobacter pylori, Neisseria meningitidis, Proteus mirabilis, Pseudomonas aeruginosa, Salmonella enterica subsp. enterica serovar Typhimurium, Escherichia coli K1 (RS218)
brenda
Rudat, A.K.; Pokhrel, A.; Green, T.J.; Gray, M.J.
Mutations in Escherichia coli polyphosphate kinase that lead to dramatically increased in vivo polyphosphate levels
J. Bacteriol.
200
e00697-17
2018
Escherichia coli (P0A7B1), Escherichia coli, Escherichia coli K12 (P0A7B1)
brenda
Bashatwah, R.M.; Khanfar, M.A.; Bardaweel, S.K.
Discovery of potent polyphosphate kinase 1 (PPK1) inhibitors using structure-based exploration of PPK1Pharmacophoric space coupled with docking analyses
J. Mol. Recognit.
31
e2726
2018
Escherichia coli (P0A7B1), Escherichia coli, Escherichia coli K12 (P0A7B1)
brenda